SIGNA™ Pulse of MRSIGNA™ Pulse of MR

Volume 39 — Autumn 2025

Our boldest ideas yet∨ EXPLORE THIS ISSUE

Introducing our
boldest ideas yet

Fotis Vlachos, PhD
Fotis Vlachos, PhD

Chief Marketing and Commercial Officer, Global MR

— GE HealthCare London, UK

 

 

 

Each year more than 300 million MR examinations are performed globally. With a projected 6% annual growth in procedures, annual volumes will exceed 400 million in just five years. Demand for MR is expanding across geographies and demographics, with the clinical need for cardiac and whole-body imaging accelerating at a faster pace. We are observing expanding access to disease-modifying therapies for Alzheimer’s disease, breast cancer and other neurodegenerative conditions, with MR being used to monitor treatment response—further augmenting its demand.

 

Across the globe, variations in population health trends, healthcare delivery models and other factors create unique needs and considerations when purchasing imaging equipment. We recognize that regions with limited access to MR imaging require lower cost and flexible or mobile equipment to maximize patient access. Conversely, we see equally large challenges in regions with a higher degree of equipment access, where fast, efficient scanning is essential to serving as many patients as possible. Despite these unique circumstances, excellent image quality is a shared expectation.

 

Tech Trends